CONTEGRA PULMONARY VALVED CONDUIT
Report
- Report Number
- 2025587-2020-00895
- Event Type
- Injury
- Date Received
- March 20, 2020
- Date of Event
- October 8, 2019
- Report Date
- March 20, 2020
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- MWH
- PMA / PMN Number
- H020003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: CHAU A ET AL. MULTIMODALITY CARDIOVASCULAR IMAGING IN THE DIAGNOSIS AND MANAGEMENT OF PROSTHETIC VALVE INFECTIVE ENDOCARDITIS IN CHILDREN REPORT OF TWO CASES AND BRIEF REVIEW OF THE LITERATURE. CARDIOL YOUNG. 2019 DEC;29(12):1526-1529. DOI: 10.1017/S1047951119002233. EPUB 2019 OCT 8. EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT THE RETURN OF THE PRODUCT, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA A LITERATURE CASE REPORT REGARDING A FEMALE PATIENT WHO WAS BORN WITH TETRALOGY OF FALLOT AND PULMONARY ATRESIA. AT (B)(6) YEAR OF AGE, THE PATIENT UNDERWENT COMPLETE REPAIR INVOLVING CLOSURE OF THE VENTRICULAR SEPTAL DEFECT AND IMPLANTATION OF A CONDUIT (MANUFACTURER NOT IDENTIFIED) BETWEEN THE RIGHT VENTRICLE AND PULMONARY ARTERY. AT (B)(6) YEARS OF AGE, THE PATIENT¿S INITIAL CONDUIT WAS REPLACED WITH A 16 MM MEDTRONIC CONTEGRA VALVED CONDUIT (SERIAL NUMBER NOT PROVIDED). AT (B)(6) YEARS OF AGE, THE PATIENT UNDERWENT TRANSCATHETER VALVE-IN-VALVE IMPLANTATION WITH A MEDTRONIC MELODY BIOPROSTHETIC VALVE (SERIAL NUMBER NOT PROVIDED) DUE TO STENOSIS OF THE CONTEGRA CONDUIT. AT (B)(6) YEARS OF AGE, THE PATIENT WAS ADMITTED WITH A FEVER OF UNKNOWN ORIGIN THAT HAD PERSISTED FOR A WEEK PRIOR TO HOSPITAL ADMISSION. TRANSTHORACIC ECHOCARDIOGRAPHY DID NOT SHOW INTRACARDIAC VEGETATIONS BUT INDICATED INCREASED STENOSIS ACROSS THE VALVE OF THE RIGHT VENTRICLE TO PULMONARY ARTERY CONDUIT. BLOOD CULTURES GREW (B)(6). CONTINUOUS INTRAVENOUS ANTIBIOTIC THERAPY WAS INITIATED. THE PATIENT¿S SIX-DAY HOSPITAL COURSE WAS COMPLICATED BY FLUID OVERLOAD WITH LOW ALBUMIN, ASCITES, PLEURAL EFFUSION, SEPSIS, AND BLOOD CULTURES THAT CONTINUED TO TEST (B)(6) DESPITE THE ANTIBIOTIC TREATMENT. A CHEST COMPUTED TOMOGRAPHY ANGIOGRAM REVEALED A SUSPECTED THROMBUS AS OPPOSED TO VEGETATION ASSOCIATED WITH THE IMPLANTED CONDUIT VALVE. SUBSEQUENTLY, THE MELODY VALVE AND CONTEGRA CONDUIT WERE SURGICALLY REMOVED AND REPLACED WITH A PULMONARY HOMOGRAFT. IT WAS CONFIRMED THAT A LARGE VEGETATION WAS IDENTIFIED DURING THE SURGERY AND WAS REMOVED WITH THE MELODY VALVE AND CONTEGRA CONDUIT. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 324770 | CONTEGRA PULMONARY VALVED CONDUIT | CONDUIT,VALVED,PULMONIC | MWH | MEDTRONIC HEART VALVES DIVISION | 200S |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 7 YR | Required Intervention |